Search bioRxiv⌕ Search

Biology subjects

Zhu, C. Y.

Publications and source records attributed to Zhu, C. Y..

2 recordsLinked to original sources

Host cyclophilin-mediated maturation of an obligate intracellular bacterial surface virulence factor

Adaptation of obligate intracellular bacteria to the eukaryotic cytoplasm creates dependencies on host factors that comprise unique infection mechanisms and vulnerabilities compared to facultative intracellular species. Here, we identify the peptidylprolyl isomerase cyclophilin A (PPIA/CypA) as a convergent host dependency in obligate intracellular bacterial pathogens. Using a host-directed functional genetic screen in the emerging tick-borne pathogen Rickettsia parkeri, we find that PPIA promotes infection and actin-based motility through an unprecedented inter-kingdom surface protein maturation event that facilitates transmembrane translocation of the actin-nucleating virulence factor Sca2. PPIA is required for efficient R. parkeri infection across human and tick cells, and pharmacological inhibition of PPIA phenocopies the loss of Sca2 in vitro and in vivo. This dependency extends to Chlamydia trachomatis and Orientia tsutsugamushi but appears absent in multiple facultative intracellular species. Targeting of host PPIA may thus represent a shared infection dependency across obligate intracellular bacterial pathogens with unmet therapeutic needs.

microbiology↗

A broad and potent neutralization epitope in SARS-related coronaviruses

Many neutralizing antibodies (nAbs) elicited to ancestral SARS-CoV-2 through natural infection and vaccination generally have reduced effectiveness to SARS-CoV-2 variants. Here we show therapeutic antibody ADG20 is able to neutralize all SARS-CoV-2 variants of concern (VOCs) including Omicron (B.1.1.529) as well as other SARS-related coronaviruses. We delineate the structural basis of this relatively escape-resistant epitope that extends from one end of the receptor binding site (RBS) into the highly conserved CR3022 site. ADG20 can then benefit from high potency through direct competition with ACE2 in the more variable RBS and interaction with the more highly conserved CR3022 site. Importantly, antibodies that are able to target this site generally neutralize all VOCs, albeit with reduced potency against Omicron. Thus, this highly conserved and vulnerable site can be exploited for design of universal vaccines and therapeutic antibodies.

microbiology↗